Ikena Oncology Files 8-K Report
Ticker: IMA · Form: 8-K · Filed: Jul 24, 2025 · CIK: 1835579
| Field | Detail |
|---|---|
| Company | Ikena Oncology, INC. (IMA) |
| Form Type | 8-K |
| Filed Date | Jul 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, corporate-event
Related Tickers: IKNA
TL;DR
IKNA filed an 8-K, likely routine, no major news yet.
AI Summary
On July 24, 2025, Ikena Oncology, Inc. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure. No specific financial transactions or material events were detailed in the provided excerpt.
Why It Matters
This filing signals that Ikena Oncology has made a disclosure to the SEC, which could pertain to various corporate events, though specifics are not detailed in this excerpt.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report with no immediately apparent negative or positive material information disclosed in the provided text.
Key Players & Entities
- Ikena Oncology, Inc. (company) — Registrant
- 0001193125-25-163990 (document_id) — Accession Number
- July 24, 2025 (date) — Report Date
- 001-40287 (company_id) — SEC File Number
- 81-1697316 (company_id) — IRS Employer Identification No.
- 645 Summer Street , Suite 101 , Boston , Massachusetts 02210 (address) — Principal executive offices
- (857) 273-8343 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing by Ikena Oncology, Inc.?
The filing is a Current Report on Form 8-K, with the primary item information listed as 'Other Events'.
On what date was this 8-K report filed?
The report was filed on July 24, 2025.
What is Ikena Oncology, Inc.'s principal executive office address?
The principal executive offices are located at 645 Summer Street, Suite 101, Boston, Massachusetts 02210.
What is the SEC file number for Ikena Oncology, Inc.?
The SEC file number for Ikena Oncology, Inc. is 001-40287.
Does the filing excerpt detail any specific material events or financial transactions?
No, the provided excerpt of the 8-K filing only indicates 'Other Events' and does not detail specific material events or financial transactions.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 24, 2025 regarding Ikena Oncology, Inc. (IMA).